Octerra Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Endoshuntendoshunt.cominNov 2022
EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip.
HardwareHealthtechMedical DevicesLincoln, US
Michael Finn-Henry(President and Member of Board of Directors)inJeremy Levin(Director)
BoardMilad Behbahaninia(Member of Board of Directors)Olivia Busk(Member of Board of Directors)
Co-investorsNew York AngelsThe Innovation Space
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.